Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 491,276 shares at $28.87 ($14.9M) on 2024-12-16, disclosed to the SEC on 2024-12-17.
Scheduled sale ($14.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.02 | 97,062 | $2.9M | 19.5% |
| 2 | $28.78 | 17,001 | $489K | 3.3% |
| 3 | $28.78 | 17,001 | $489K | 3.3% |
| 4 | $28.79 | 16,667 | $480K | 3.2% |
| 5 | $28.79 | 16,667 | $480K | 3.2% |
| 6 | $28.87 | 2,792 |
| $81K |
| 0.5% |
| 7 | $28.87 | 2,792 | $81K | 0.5% |
| 8 | $28.89 | 31,934 | $923K | 6.2% |
| 9 | $28.89 | 31,934 | $923K | 6.2% |
| 10 | $29.78 | 15,600 | $465K | 3.1% |
| 11 | $30.35 | 41,667 | $1.3M | 8.5% |
| 12 | $30.35 | 41,667 | $1.3M | 8.5% |
| 13 | $32.01 | 68,707 | $2.2M | 14.7% |
| 14 | $32.01 | 68,707 | $2.2M | 14.7% |
| 15 | $32.63 | 10,539 | $344K | 2.3% |
| 16 | $32.63 | 10,539 | $344K | 2.3% |
| Total | $30.41 avg | 491,276 | $14.9M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |